Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis.
Authors: Sivapiromrat AK; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Emory College, Emory University, Atlanta, GA, USA., Suppakitjanusant P; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Wang Y; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA., Hu C; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Binongo J; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Hunt WR; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Weinstein S; Emory College, Emory University, Atlanta, GA, USA., Jathal I; Emory College, Emory University, Atlanta, GA, USA., Alvarez JA; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Chassaing B; INSERM U1016, Team 'Mucosal Microbiota in Chronic Inflammatory Diseases', CNRS, UMR, 8104, Université Paris Cité, Paris, France., Ziegler TR; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Atlanta VA Medical Center, Decatur, GA, USA., Gewirtz AT; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA., Tangpricha V; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Atlanta VA Medical Center, Decatur, GA, USA.
Source: Contemporary clinical trials communications [Contemp Clin Trials Commun] 2024 Feb 18; Vol. 38, pp. 101278. Date of Electronic Publication: 2024 Feb 18 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101671157 Publication Model: eCollection Cited Medium: Internet ISSN: 2451-8654 (Electronic) Linking ISSN: 24518654 NLM ISO Abbreviation: Contemp Clin Trials Commun Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2451-8654
DOI:10.1016/j.conctc.2024.101278